Executives of Top Pharmacy Benefit Managers to Testify Before Congress on July 23

Wednesday, 10 July 2024, 10:44

Top pharmacy benefit managers (PBMs) are scheduled to testify before Congress on July 23, in light of the FTC report emphasizing their significant market influence. The upcoming hearing aims to address concerns regarding the dominance of leading PBMs and their impact on the healthcare sector. Stay informed on this crucial event shaping the industry landscape.
Seeking Alpha
Executives of Top Pharmacy Benefit Managers to Testify Before Congress on July 23

Key Points:

July 23 Hearing: Executives from top PBMs will testify before Congress.

  • Market Dominance: FTC report highlights the significant influence of PBMs in the market.

Conclusion:

Stay Informed: The imminent congressional hearing sheds light on the dominance of leading PBMs, prompting discussions on their role in the healthcare industry.


This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.


Related posts


Newsletter

Get the most reliable and up-to-date financial news with our curated selections. Subscribe to our newsletter for convenient access and enhance your analytical work effortlessly.

Subscribe